As was observed in BALB/cJ mice, the absence of CD169 reduced FVC infection at the draining pLN with concomitant enhancement in the spleen and higher levels of splenomegaly than B6 controls (Figures 2I–2K). This evidence concerns the gene SIGLEC1 and Splenomegaly.